A Study to Evaluate the Efficacy and Safety of BIIB093 in Participants With Brain Contusion
- First Posted Date
- 2019-05-17
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- Remedy Pharmaceuticals, Inc.
- Target Recruit Count
- 92
- Registration Number
- NCT03954041
- Locations
- ๐บ๐ธ
Grady Memorial Hospital, Atlanta, Georgia, United States
๐บ๐ธGoodman Campbell Brain and Spine, Carmel, Indiana, United States
๐บ๐ธUniversity of Maryland Medical Center, Baltimore, Maryland, United States
Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction
- First Posted Date
- 2016-08-12
- Last Posted Date
- 2024-11-25
- Lead Sponsor
- Remedy Pharmaceuticals, Inc.
- Target Recruit Count
- 535
- Registration Number
- NCT02864953
- Locations
- ๐บ๐ธ
Maine Medical Center, Portland, Maine, United States
๐บ๐ธLyerly Neurosurgery Baptist Health, Jacksonville, Florida, United States
๐บ๐ธUniversity of Maryland, Baltimore, Maryland, United States
Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals
- Conditions
- Interventions
- First Posted Date
- 2013-02-18
- Last Posted Date
- 2024-11-12
- Lead Sponsor
- Remedy Pharmaceuticals, Inc.
- Target Recruit Count
- 86
- Registration Number
- NCT01794182
- Locations
- ๐บ๐ธ
University of Maryland School of Medicine, Baltimore, Maryland, United States
๐บ๐ธUPMC Presbyterian Hospital, Pittsburgh, Pennsylvania, United States
๐บ๐ธCleveland Clinic, Cleveland, Ohio, United States
Glyburide (RP-1127) for Traumatic Brain Injury (TBI)
- First Posted Date
- 2011-10-18
- Last Posted Date
- 2024-11-11
- Lead Sponsor
- Remedy Pharmaceuticals, Inc.
- Target Recruit Count
- 29
- Registration Number
- NCT01454154
- Locations
- ๐บ๐ธ
UPMC Presbyterian Hospital, Pittsburgh, Pennsylvania, United States
๐บ๐ธUniversity of Maryland Medical Center, Shock Trauma Center, Baltimore, Maryland, United States
๐บ๐ธUniversity of California, San Diego, San Diego, California, United States
Glyburide Advantage in Malignant Edema and Stroke Pilot
- First Posted Date
- 2010-12-31
- Last Posted Date
- 2024-11-22
- Lead Sponsor
- Remedy Pharmaceuticals, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT01268683
- Locations
- ๐บ๐ธ
University of Maryland Medical Center, Baltimore, Maryland, United States
๐บ๐ธRush University Medical Center, Chicago, Illinois, United States
๐บ๐ธUniversity of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States